Genprex GNPX
NASDAQ GNPX
$2.63 +0.07 (+2.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

Genprex (GNPX) Non Operating Investment Income (2023 - 2024)

Updated

Genprex's Non Operating Investment Income was $545.00 in Q4 2024, compared with -$886.00 a year earlier.

Analysis

Genprex (GNPX) Non Operating Investment Income (2023 - 2024) Analysis & Trends

For FY2024, Non Operating Investment Income at Genprex came in at -$570.00.

  • In earlier years, Non Operating Investment Income was -$18,676 in FY2023.
  • The Q4 2024 figure marks the highest quarterly Non Operating Investment Income since Q2 2023.
  • Per Business Quant data, GNPX's Non Operating Investment Income in the three quarters before Q4 2024 was -$629.00 (Q3 2024), -$620.00 (Q2 2024) and $135.00 (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Genprex 1.33 Mn -40.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 545.00
Sep 30, 2024 -629.00
Jun 30, 2024 -620.00
Mar 31, 2024 135.00
Dec 31, 2023 -886.00
Sep 30, 2023 -13,307.00
Jun 30, 2023 2,208.00
Mar 31, 2023 -6,691.00
API Access

Genprex Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=GNPX&period=max&api_key=YOUR_API_KEY